![](https://investorshub.advfn.com/uicon/363979.png?cb=1614887548)
Thursday, May 14, 2015 11:09:34 AM
KM 391 – Novel Autism Compound
KM 277 - Osteo-arthritis and Asthma
KM 362 - Demyelination
KM 3174 - Early stage developmental compound in the treatment of cancer
KM 732 - Reduction of high blood pressure
So there is still a lot of of other drugs in the pipeline but their not moving forward due to focusing on K,B,and P which IMO is a smart move. once money is available either after a partnership or one of the three goes to market I believe they will pick one of these to advance into trials. I think they would go with KM391 which from the small amount of pre-clinical testing that was done it showed promise. This wont happen for another three years IMO but it's great that we have other potential blockbuster drugs that we have just scratched the surface with. Plus if cellceutix is bought out it would help in obtaining a higher price maybe not that much but a little seeing that their pre-clinical status so not actual hard data in humans yet.
http://cellceutix.com/pre-clinical-compounds/#sthash.ccj4hjhx.dpbs
Go CTIX
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM